<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font20 { font-size : 20; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font20">and </span>
   <span class="font14">oseltamivir </span>
   <span class="font13">was </span>
   <span class="font13">that </span>
   <span class="font13">active </span>
   <span class="font13">with </span>
   <span class="font12">were </span>
   <span class="font12">The </span>
   <span class="font12">for </span>
   <span class="font12">SARS-CoV- </span>
   <span class="font12">structure </span>
   <span class="font11">protein </span>
   <span class="font11">influenza </span>
   <span class="font11">used </span>
   <span class="font11">{background </span>
   <span class="font11">neuraminidase </span>
   <span class="font11">not </span>
   <span class="font11">from </span>
   <span class="font11">[]. </span>
   <span class="font11">are </span>
   <span class="font11">found </span>
   <span class="font11">Pol/RdRp </span>
   <span class="font11">center </span>
   <span class="font11">margin </span>
   <span class="font11">CLpro </span>
   <span class="font11">antiviral </span>
   <span class="font11">{border-style </span>
   <span class="font10">against </span>
   <span class="font10">binding </span>
   <span class="font10">patients </span>
   <span class="font10">site </span>
   <span class="font10">structural </span>
   <span class="font10">PLpro </span>
   <span class="font10">carboxylic </span>
   <span class="font10">group </span>
   <span class="font10">px;} </span>
   <span class="font10">residues </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">docking </span>
   <span class="font10">its </span>
   <span class="font10">there </span>
   <span class="font10">this </span>
   <span class="font10">[], </span>
   <span class="font10">between </span>
   <span class="font10">coronavirus </span>
   <span class="font10">treatment </span>
   <span class="font10">which </span>
   <span class="font10">Alignment </span>
   <span class="font10">acid </span>
   <span class="font10">proteins </span>
   <span class="font10">two </span>
   <span class="font10">NRBD, </span>
   <span class="font10">have </span>
   <span class="font10">difference </span>
   <span class="font10">dotted </span>
   <span class="font10">similar </span>
   <span class="font10">study </span>
   <span class="font10">viral </span>
   <span class="font10">CPY </span>
   <span class="font10">NRBD </span>
   <span class="font10">alignment </span>
   <span class="font10">effective </span>
   <span class="font10">our </span>
   <span class="font10">revealed </span>
   <span class="font10">vitro </span>
   <span class="font10">whether </span>
   <span class="font10">(Fig. </span>
   <span class="font10">COVID- </span>
   <span class="font10">COVID-. </span>
   <span class="font10">ID: </span>
   <span class="font10">PLpro, </span>
   <span class="font10">conformation </span>
   <span class="font10">effect </span>
   <span class="font10">key </span>
   <span class="font10">model </span>
   <span class="font10">structures </span>
   <span class="font10">virus </span>
   <span class="font10">(PDB </span>
   <span class="font10">N-terminal </span>
   <span class="font10">RNA </span>
   <span class="font10">RNA-binding </span>
   <span class="font10">Right </span>
   <span class="font10">clinical </span>
   <span class="font10">papain-like </span>
   <span class="font10">reasonable </span>
   <span class="font10">use </span>
   <span class="font10">using </span>
   <span class="font10">Fig. </span>
   <span class="font10">Left </span>
   <span class="font10">also </span>
   <span class="font10">analyzed </span>
   <span class="font10">based </span>
   <span class="font10">days </span>
   <span class="font10">did </span>
   <span class="font10">domain </span>
   <span class="font10">energy </span>
   <span class="font10">homology </span>
   <span class="font10">inhibitor </span>
   <span class="font10">panel: </span>
   <span class="font10">similarity </span>
   <span class="font10">sites </span>
   <span class="font10">âˆ’. </span>
   <span class="font10">RNA-directed </span>
   <span class="font10">Table </span>
   <span class="font10">can </span>
   <span class="font10">case </span>
   <span class="font10">group. </span>
   <span class="font10">positive </span>
   <span class="font10">protease; </span>
   <span class="font10">px; </span>
   <span class="font10">remission </span>
   <span class="font10">results </span>
   <span class="font10">such </span>
   <span class="font10">{font-family </span>
   <span class="font10">(nÂ </span>
   <span class="font10">Oseltamivir </span>
   <span class="font10">SARS-CoV </span>
   <span class="font10">Therefore, </span>
   <span class="font10">analysis </span>
   <span class="font10">analyze </span>
   <span class="font10">could </span>
   <span class="font10">domain; </span>
   <span class="font10">font-size </span>
   <span class="font10">inhibit </span>
   <span class="font10">inside </span>
   <span class="font10">interactions </span>
   <span class="font10">marked </span>
   <span class="font10">non-remission </span>
   <span class="font10">oseltamivir. </span>
   <span class="font10">panel </span>
   <span class="font10">region </span>
   <span class="font10">shows </span>
   <span class="font10">through </span>
   <span class="font10">(.) </span>
   <span class="font10">CLpro, </span>
   <span class="font10">China </span>
   <span class="font10">NC, </span>
   <span class="font10">NRBD: </span>
   <span class="font10">Non-use </span>
   <span class="font10">PLpro: </span>
   <span class="font10">Pol/RdRp, </span>
   <span class="font10">Pol/RdRp: </span>
   <span class="font10">Protein </span>
   <span class="font10">SARS </span>
   <span class="font10">TM-align </span>
   <span class="font10">Wuhan </span>
   <span class="font10">bind </span>
   <span class="font10">centre </span>
   <span class="font10">disease </span>
   <span class="font10">double; </span>
   <span class="font10">evaluated </span>
   <span class="font10">evaluation </span>
   <span class="font10">further </span>
   <span class="font10">group, </span>
   <span class="font10">has </span>
   <span class="font10">history </span>
   <span class="font10">into </span>
   <span class="font10">models </span>
   <span class="font10">neuraminidase; </span>
   <span class="font10">novel </span>
   <span class="font10">other </span>
   <span class="font10">program </span>
   <span class="font10">protein, </span>
   <span class="font10">response </span>
   <span class="font10">suggesting </span>
   <span class="font10">value </span>
   <span class="font10">workers </span>
   <span class="font10">Â±Â </span>
   <span class="font10">(PÂ </span>
   <span class="font10">.%, </span>
   <span class="font10">C-like </span>
   <span class="font10">COVID-, </span>
   <span class="font10">Docking </span>
   <span class="font10">Elsevier </span>
   <span class="font10">Hospital </span>
   <span class="font10">Ramachandran </span>
   <span class="font10">Random </span>
   <span class="font10">SARS-CoV-, </span>
   <span class="font10">Science </span>
   <span class="font10">above </span>
   <span class="font10">all </span>
   <span class="font10">bid </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">centers </span>
   <span class="font10">course </span>
   <span class="font10">different </span>
   <span class="font10">drug, </span>
   <span class="font10">evaluate </span>
   <span class="font10">framed </span>
   <span class="font10">improve </span>
   <span class="font10">ineffective </span>
   <span class="font10">kcal/mol, </span>
   <span class="font10">ligand </span>
   <span class="font10">main </span>
   <span class="font10">molecular </span>
   <span class="font10">more </span>
   <span class="font10">most </span>
   <span class="font10">neuraminidase. </span>
   <span class="font10">outbreak </span>
   <span class="font10">patientsâ€™ </span>
   <span class="font10">pocket </span>
   <span class="font10">program. </span>
   <span class="font10">protease </span>
   <span class="font10">red </span>
   <span class="font10">research </span>
   <span class="font10">respectively </span>
   <span class="font10">respiratory </span>
   <span class="font10">retrospective </span>
   <span class="font10">selected </span>
   <span class="font10">severe </span>
   <span class="font10">should </span>
   <span class="font10">solid; </span>
   <span class="font10">suggested </span>
   <span class="font10">suitable </span>
   <span class="font10">symptoms </span>
   <span class="font10">targets </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">âˆ’.Â </span>
   <span class="font10">â€"Â </span>
   <span class="font10">(.%) </span>
   <span class="font10">(A) </span>
   <span class="font10">(Table </span>
   <span class="font10">Abbreviations: </span>
   <span class="font10">Data </span>
   <span class="font10">Finally, </span>
   <span class="font10">Res. </span>
   <span class="font10">SARS-CoV, </span>
   <span class="font10">SARS-CoV-. </span>
   <span class="font10">SARS-CoV. </span>
   <span class="font10">Sci. </span>
   <span class="font10">Subsequently, </span>
   <span class="font10">Union </span>
   <span class="font10">acid; </span>
   <span class="font10">age </span>
   <span class="font10">bold </span>
   <span class="font10">cell </span>
   <span class="font10">compare </span>
   <span class="font10">compared </span>
   <span class="font10">considered </span>
   <span class="font10">courier; </span>
   <span class="font10">crystal </span>
   <span class="font10">described </span>
   <span class="font10">determined </span>
   <span class="font10">diseases, </span>
   <span class="font10">effectively </span>
   <span class="font10">em; </span>
   <span class="font10">groups </span>
   <span class="font10">hospitalization </span>
   <span class="font10">important </span>
   <span class="font10">including </span>
   <span class="font10">infection </span>
   <span class="font10">inhibitors </span>
   <span class="font10">line); </span>
   <span class="font10">magentas. </span>
   <span class="font10">medical </span>
   <span class="font10">method </span>
   <span class="font10">modeling. </span>
   <span class="font10">no. </span>
   <span class="font10">oseltamivir, </span>
   <span class="font10">panel:D </span>
   <span class="font10">polymerase; </span>
   <span class="font10">possibility </span>
   <span class="font10">primary </span>
   <span class="font10">pro </span>
   <span class="font10">progression </span>
   <span class="font10">proportion </span>
   <span class="font10">pt;} </span>
   <span class="font10">rate </span>
   <span class="font10">resource </span>
   <span class="font10">score </span>
   <span class="font10">sex </span>
   <span class="font10">shown </span>
   <span class="font10">significant </span>
   <span class="font10">strong </span>
   <span class="font10">their </span>
   <span class="font10">therapeutic </span>
   <span class="font10">three </span>
   <span class="font10">verify </span>
   <span class="font10">who </span>
   <span class="font10">work </span>
  </p>
 </body>
</html>
